{"url_path":"/sec/txmd/8-k/2026-08-11/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/25743/0001213900-26-087756-index.html","accession_number":"0001213900-26-087756","cik":"0000025743","ticker":"TXMD","issuer_name":"TherapeuticsMD, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/25743/0001213900-26-087756-index.html","primary_entity_key":"0000025743","primary_entity_name":"TherapeuticsMD, Inc."},"word_count":29,"has_tables":true,"body_markdown":"**Item 2.02 Results of Operations and Financial\nCondition.**\n\n \n\nThe information provided in Item 7.01 of this\nCurrent Report on Form 8-K is incorporated in this Item 2.02 by reference."}